Anna Marei Eichhoff

528 total citations
7 papers, 402 citations indexed

About

Anna Marei Eichhoff is a scholar working on Radiology, Nuclear Medicine and Imaging, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Anna Marei Eichhoff has authored 7 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Radiology, Nuclear Medicine and Imaging, 2 papers in Infectious Diseases and 2 papers in Molecular Biology. Recurrent topics in Anna Marei Eichhoff's work include Monoclonal and Polyclonal Antibodies Research (3 papers), Adenosine and Purinergic Signaling (2 papers) and Virus-based gene therapy research (2 papers). Anna Marei Eichhoff is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (3 papers), Adenosine and Purinergic Signaling (2 papers) and Virus-based gene therapy research (2 papers). Anna Marei Eichhoff collaborates with scholars based in Germany, France and United States. Anna Marei Eichhoff's co-authors include Friedrich Koch‐Nolte, Friedrich Haag, Carsten Schwan, Klaus Aktories, Sarah A. Kuehne, Nigel P. Minton, Dena Lyras, Stacey L. Burgess, Sahil Adriouch and Carrie A. Cowardin and has published in prestigious journals such as Scientific Reports, Journal of the American Society of Nephrology and Frontiers in Oncology.

In The Last Decade

Anna Marei Eichhoff

7 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Marei Eichhoff Germany 7 147 142 91 88 85 7 402
K Togashi Japan 12 30 0.2× 71 0.5× 33 0.4× 41 0.5× 52 0.6× 58 431
Anselmo Jiro Kamada Brazil 7 35 0.2× 218 1.5× 51 0.6× 168 1.9× 53 0.6× 15 370
Ivo S. Hansen Netherlands 8 41 0.3× 102 0.7× 92 1.0× 265 3.0× 45 0.5× 8 441
Akihiko Tamura Japan 12 18 0.1× 147 1.0× 27 0.3× 98 1.1× 42 0.5× 44 454
Steven Levitte United States 11 155 1.1× 100 0.7× 23 0.3× 104 1.2× 115 1.4× 27 487
Elizabeth Elder United Kingdom 12 29 0.2× 109 0.8× 26 0.3× 77 0.9× 188 2.2× 15 369
Amy Cross United Kingdom 14 82 0.6× 104 0.7× 6 0.1× 184 2.1× 54 0.6× 22 491
Saifur Rahman United States 13 26 0.2× 116 0.8× 19 0.2× 377 4.3× 45 0.5× 27 567
Lena Tanaka United States 8 64 0.4× 156 1.1× 25 0.3× 476 5.4× 62 0.7× 12 634
Falko Apel Germany 5 48 0.3× 170 1.2× 23 0.3× 325 3.7× 31 0.4× 6 456

Countries citing papers authored by Anna Marei Eichhoff

Since Specialization
Citations

This map shows the geographic impact of Anna Marei Eichhoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Marei Eichhoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Marei Eichhoff more than expected).

Fields of papers citing papers by Anna Marei Eichhoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Marei Eichhoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Marei Eichhoff. The network helps show where Anna Marei Eichhoff may publish in the future.

Co-authorship network of co-authors of Anna Marei Eichhoff

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Marei Eichhoff. A scholar is included among the top collaborators of Anna Marei Eichhoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Marei Eichhoff. Anna Marei Eichhoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Abad, Catalina, Romain Hardet, Anna Marei Eichhoff, et al.. (2020). Evaluation of P2X7 Receptor Function in Tumor Contexts Using rAAV Vector and Nanobodies (AAVnano). Frontiers in Oncology. 10. 1699–1699. 13 indexed citations
2.
Eichhoff, Anna Marei, Kathleen Börner, Friedrich Haag, et al.. (2019). Nanobody-Enhanced Targeting of AAV Gene Therapy Vectors. Molecular Therapy — Methods & Clinical Development. 15. 211–220. 69 indexed citations
3.
Koch‐Nolte, Friedrich, Anna Marei Eichhoff, Nicole Schwarz, et al.. (2019). Novel biologics targeting the P2X7 ion channel. Current Opinion in Pharmacology. 47. 110–118. 37 indexed citations
4.
Seifert, Larissa, Elion Hoxha, Anna Marei Eichhoff, et al.. (2018). The Most N-Terminal Region of THSD7A Is the Predominant Target for Autoimmunity in THSD7A-Associated Membranous Nephropathy. Journal of the American Society of Nephrology. 29(5). 1536–1548. 49 indexed citations
5.
Cowardin, Carrie A., Erica L. Buonomo, Mahmoud Saleh, et al.. (2016). The binary toxin CDT enhances Clostridium difficile virulence by suppressing protective colonic eosinophilia. Nature Microbiology. 1(8). 16108–16108. 138 indexed citations
6.
Unger, Mandy, Anna Marei Eichhoff, Stephan Menzel, et al.. (2015). Selection of Nanobodies that Block the Enzymatic and Cytotoxic Activities of the Binary Clostridium Difficile Toxin CDT. Scientific Reports. 5(1). 7850–7850. 54 indexed citations
7.
Bannas, Peter, Alexander Lenz, Lennart Well, et al.. (2015). Molecular imaging of tumors with nanobodies and antibodies: Timing and dosage are crucial factors for improved in vivo detection. Contrast Media & Molecular Imaging. 10(5). 367–378. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026